Yunshi Zhong

Dr. Yunshi Zhong


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2021 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
BLBing Li
Bing Li
ZQZhi-Peng Qi
Zhi-Peng Qi
DHDong-Li He
Dong-Li He
ZCZhang-Han Chen
Zhang-Han Chen
JLJing-Yi Liu
Jing-Yi Liu
YZYunshi Zhong
Yunshi Zhong
Background: NOD-like receptors affect multiple stages of cancer progression in many malignancies. NACHT, LRR, and PYD domain-containing protein 7 (NLRP7) is a member of the NOD-like receptor family, although its role in tumorigenesis remains unclear. By analyzing clinical samples, we found that NLRP7 protein levels were upregulated in colorectal cancer (CRC). We proposed the hypothesis that a high level of NLRP7 in CRC may promote tumor progression. Here, we further investigated the role of NLRP7 in CRC and the underlying mechanism. Methods: NLRP7 expression in human CRC and adjacent non-tumorous tissues was examined by quantitative real-time polymerase chain reaction (qRT-PCR), western blotting, and immunohistochemistry. The effect of NLRP7 in CRC progression was investigated in vitro and in vivo. Proteins interacting with NLRP7 were identified by immunoprecipitation and mass spectrometry analysis while immunofluorescence staining revealed the cellular location of the proteins. Cellular ubiquitination and protein stability assays were applied to demonstrate the ubiquitination effect on NLRP7. Cloning and mutagenesis were used to identify a lysine acceptor site that mediates NLRP7 ubiquitination. Cytokines/chemokines affected by NLRP7 were identified by RNA sequencing, qRT-PCR, and enzyme-linked immunosorbent assay. Macrophage phenotypes were determined using qRT-PCR, flow cytometry, and immunohistochemistry. Results: NLRP7 protein levels, but not mRNA levels, were upregulated in CRC, and increased NLRP7 protein expression was associated with poor survival. NLRP7 promoted tumor cell proliferation and metastasis in vivo and in vitro and interacted with ubiquitin-specific protease 10, which catalyzed its deubiquitination in CRC cells. NLRP7 stability and protein levels in CRC cells were modulated by ubiquitination and deubiquitination, and NLRP7 was involved in the ubiquitin-specific protease 10 promotion of tumor progression and metastasis in CRC. K379 was an important lysine acceptor site that mediates NLRP7 ubiquitination in CRC cells. In CRC, NLRP7 promoted the polarization of pro-tumor M2-like macrophages by inducing the secretion of C-C motif chemokine ligand 2. Furthermore, NLRP7 promoted NF-κB nuclear translocation and activation of C-C motif chemokine ligand 2 transcription. Conclusions: We showed that NLRP7 promotes CRC progression and revealed an as-yet-unidentified mechanism by which NLRP7 induces the polarization of pro-tumor M2-like macrophages. These results suggest that NLRP7 could serve as a biomarker and novel therapeutic target for the treatment of CRC.

21 January 2021 in World Journal of Gastroenterology
Verified
Journal Article
Open access
BLBing Li
Bing Li
SCShi-Lun Cai
Shi-Lun Cai
WTWei-Min Tan
Wei-Min Tan
JLJi-Chun Li
Ji-Chun Li
AYAyimukedisi Yalikong
Ayimukedisi Yalikong
YZYunshi Zhong
Yunshi Zhong
Comparative study on artificial intelligence systems for detecting early esophageal squamous cell carcinoma between narrow-band and white-light imaging

14 September 2023 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
Qinqin HuQinqin Hu
Qinqin Hu
ZTZongxuan Tong
Zongxuan Tong
AYAyimukedisi Yalikong
Ayimukedisi Yalikong
LGLi-Ping Ge
Li-Ping Ge
QSQiang Shi
Qiang Shi
HGHongzhou Gu
Hongzhou Gu

26 November 2018 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
BLBing Li
Bing Li
TCTao Chen
Tao Chen
ZQZhi-Peng Qi
Zhi-Peng Qi
LYLi-Qing Yao
Li-Qing Yao
MXMei-Dong Xu
Mei-Dong Xu
YZYunshi Zhong
Yunshi Zhong

2 August 2019 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
BLBing Li
Bing Li
QSQiang Shi
Qiang Shi
ZQZhi-Peng Qi
Zhi-Peng Qi
LYLi-Qing Yao
Li-Qing Yao
MXMei-Dong Xu
Mei-Dong Xu
YZYunshi Zhong
Yunshi Zhong

15 December 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
ZQZhi‐Peng Qi
Zhi‐Peng Qi
AYAyimukedisi Yalikong
Ayimukedisi Yalikong
JZJia‐Wei Zhang
Jia‐Wei Zhang
SCShi‐Lun Cai
Shi‐Lun Cai
BLBing Li
Bing Li
PZPinghong Zhou
Pinghong Zhou
Histone deacetylase 2 (HDAC2), a member of the Histone deacetylase family, plays a vital role in various carcinomas. In this study, we identified that HDAC2 expression levels are associated with liver metastasis, higher T stages and poor prognosis in colorectal cancer. HDAC2 down‐regulation via lentivirus‐mediated expression of HDAC2‐targeting shRNA reduced the in vitro migration and invasion ability of HCT116 cell as well as their liver metastasis in nude mouse xenografts. Mechanistically, HDAC2 promotes epithelial‐mesenchymal transition (EMT) in colorectal cancer cells by combining HDAC1 with EZH2 (a key histone methyltransferase), possibly through the modular scaffold function of a new lncRNA, ENSG00000274093.1. HDAC2 thus appears to promote CRC cell migration and invasion through binding HDAC1 and EZH2 via ENSG00000274093.1.